Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita

Int J Hematol. 2006 Apr;83(3):275-6. doi: 10.1532/IJH97.06030.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Aplastic / complications
  • Anemia, Aplastic / mortality
  • Anemia, Aplastic / therapy*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Dyskeratosis Congenita / complications
  • Dyskeratosis Congenita / mortality
  • Dyskeratosis Congenita / therapy*
  • Hematopoietic Stem Cell Transplantation* / mortality
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Remission Induction
  • Survival Rate
  • Treatment Outcome

Substances

  • Immunosuppressive Agents